Camelot Portfolios’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,016
Closed -$323K 224
2020
Q4
$323K Sell
3,016
-279
-8% -$26.8K 0.17% 150
2020
Q3
$289K Sell
3,295
-336
-9% -$31.6K 0.18% 145
2020
Q2
$356K Sell
3,631
-3,018
-45% -$266K 0.23% 116
2020
Q1
$507K Buy
6,649
+852
+15% +$72.6K 0.28% 94
2019
Q4
$513K Buy
5,797
+952
+20% +$79K 0.22% 116
2019
Q3
$367K Buy
4,845
+476
+11% +$32.6K 0.17% 136
2019
Q2
$318K Sell
4,369
-307
-7% -$24.1K 0.13% 169
2019
Q1
$377K Sell
4,676
-29
-0.6% -$2.37K 0.16% 153
2018
Q4
$434K Sell
4,705
-2,551
-35% -$224K 0.2% 128
2018
Q3
$686K Buy
7,256
+56
+0.8% +$5.31K 0.31% 91
2018
Q2
$667K Hold
7,200
0.28% 95
2018
Q1
$681K Buy
7,200
+1,302
+22% +$143K 0.32% 87
2017
Q4
$570K Buy
5,898
+600
+11% +$56.5K 0.27% 90
2017
Q3
$471K Hold
5,298
0.23% 95
2017
Q2
$384K Buy
+5,298
New +$356K 0.19% 105
2015
Q3
Sell
-3,763
Closed -$253K 152
2015
Q2
$253K Buy
3,763
+263
+8% +$17.2K 0.15% 136
2015
Q1
$205K Sell
3,500
-150
-4% -$9.06K 0.12% 150
2014
Q4
$239K Hold
3,650
0.14% 139
2014
Q3
$211K Hold
3,650
0.12% 146
2014
Q2
$206K Buy
+3,650
New +$191K 0.13% 147

Other funds holding ABBV